2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias

Abstract

1. Preamble; 2. Introduction; 3. Estimation of total cardiovascular risk and implications for dyslipidaemia management; 4. New low-density lipoprotein cholesterol-lowering therapies; 5. Combination of lipid-lowering therapies during index hospitalization for acute coronary syndromes; 6. Lipoprotein(a); 7. Hypertriglyceridaemia; 8. Primary prevention in people with human immunodeficiency virus infection; 9. Patients with cancer at high or very high chemotherapy-related cardiovascular toxicity risk; 10. Dietary supplements; 11. Evidence tables; 12. Data availability statement; 13. Author information; 14. Appendix; 15. References